Skip to main content
Catherine J. Lee

Catherine J. Lee, MD

Languages spoken: English

Clinical Locations

  • Clinic 2D/E BMT/Hematology-Malignant

    801-585-2626
  • Catherine J. Lee, MD is an Associate Professor of Medicine in the Division of Hematology/BMT at the Huntsman Cancer Center, University of Utah.

    Dr. Catherine Lee's clinical expertise is in Blood and Marrow Transplantation (BMT) & Cellular Therapy. She specializes in autologous and allogeneic hematopoietic cell transplants for the treatment of malignant and benign hematologic diseases in adult patients. She also directs the clinical cellular therapy program and provides both standard-of-care cellular therapy treatments and those being tested in clinical trials. Furthermore, she leads the Chronic Graft-versus-Host Disease/Long-Term Follow-Up Program for patients who have received hematopoietic cell transplantation or other immune-cellular therapies. This program is designed to monitor the health and quality of life of patients after transplant, and also provides medical care specific to patients with chronic GVHD and late effects of hematopoietic cell transplantation or other cellular therapies. Her research portfolio includes design of clinical trials for chronic GVHD, implementation of interventions to improve access to high-quality BMT care, and optimizing the health of post-transplant/cellular therapy patients. She is also the local principal investigator for clinical trials surrounding CAR-T cell therapy, post-transplant maintenance strategies to prevent AML relapse, and novel conditioning regimens for MDS/AML. She is an active member of the American Society for Transplantation and Cellular Therapy (ASTCT), ASTCT Survivorship Special Interest Group, BMT CTN Steering Committee Member of the Toxicity and Supportive Care Committee, and the National Marrow Donor Program/Be The Match member of the Featured Trial Review Committee for the Jason Carter Clinical Trials Search and Support (CTSS).

    Specialties

    Board Certification and Academic Information

    Academic Departments Internal Medicine - Primary
    Academic Divisions

    Patient Rating

    4.9 /5

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    April 23, 2022

    Doctor Lee was so patient in answering my questions, and was up front in answering. Helped me leave feeling like I had someone looking out for me and would do her best to help.

    February 20, 2022

    Her explanations were easy to understand

    February 12, 2022

    Dr. Lee and everyone who works with her were very professional and very caring of their treatment for me.

  • Catherine J. Lee, MD is an Associate Professor of Medicine in the Division of Hematology/BMT at the Huntsman Cancer Center, University of Utah.

    Dr. Catherine Lee's clinical expertise is in Blood and Marrow Transplantation (BMT) & Cellular Therapy. She specializes in autologous and allogeneic hematopoietic cell transplants for the treatment of malignant and benign hematologic diseases in adult patients. She also directs the clinical cellular therapy program and provides both standard-of-care cellular therapy treatments and those being tested in clinical trials. Furthermore, she leads the Chronic Graft-versus-Host Disease/Long-Term Follow-Up Program for patients who have received hematopoietic cell transplantation or other immune-cellular therapies. This program is designed to monitor the health and quality of life of patients after transplant, and also provides medical care specific to patients with chronic GVHD and late effects of hematopoietic cell transplantation or other cellular therapies. Her research portfolio includes design of clinical trials for chronic GVHD, implementation of interventions to improve access to high-quality BMT care, and optimizing the health of post-transplant/cellular therapy patients. She is also the local principal investigator for clinical trials surrounding CAR-T cell therapy, post-transplant maintenance strategies to prevent AML relapse, and novel conditioning regimens for MDS/AML. She is an active member of the American Society for Transplantation and Cellular Therapy (ASTCT), ASTCT Survivorship Special Interest Group, BMT CTN Steering Committee Member of the Toxicity and Supportive Care Committee, and the National Marrow Donor Program/Be The Match member of the Featured Trial Review Committee for the Jason Carter Clinical Trials Search and Support (CTSS).

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions

    Research interests

    • Telemedicine
    • Cellular Therapy
    • Allogeneic Stem Cell Transplantation
    • Autologous Stem Cell Transplantation
    • Long Term Complications and Survivorship Issues after Allogeneic Stem Cell Transplantation
    • Biomarkers and New Treatments for Chronic Graft-Versus Host Disease
    • Ancillary and Supportive Care for Chronic Graft-Versus-Host Disease
    • Multidisciplinary Interventions and Patient Reported Outcomes in the Assessment of Response to Therapy in Chronic Graft-Versus Host Disease

    Education history

    Fellowship Blood and Marrow Transplantation - Stanford School of Medicine Fellow
    Blood and Marrow Transplantation - Fred Hutchinson/SCCA Blood and Marrow Transplant Program Visiting Fellow
    Fellowship Hematology-Oncology - University of Pittsburgh Cancer Institute Fellow
    Pain and Palliative Care - Memorial Sloan Kettering Cancer Center Fellow
    Professional Medical Medicine - New York University School of Medicine M.D.
    Public Health Medicine - Johns Hopkins University B.A.